Effects of Physical Inactivity on Insulin Sensitivity, Appetite, Energy Balance, and Cardiovascular Responses in Humans.
Short-term Effects of Physical Inactivity on Insulin Sensitivity, Appetite, Energy Balance, and Cardiovascular Responses in Healthy Humans.
1 other identifier
interventional
8
1 country
1
Brief Summary
Physical inactivity is a significant predictor of major non-communicable diseases such as type 2 diabetes (7%), cardiovascular disease (6%), musculoskeletal disorders and some cancers, and has been proposed to be the 4th leading cause of death worldwide. Reduced physical activity leads to an impaired function of the hormone insulin and increased adiposity. Thus, the elimination of physical inactivity would remove between 6% and 10% of the major non-communicable diseases and increase life expectancy. The aim of the study is to investigate the effects of a short-term (2-day) period of reduced physical activity, with and without a proportional decrease in energy intake, on the action of insulin to regulate blood sugar fluctuations, appetite, and cardiovascular parameters (heart rate, cardiac output, stroke volume, blood flow, arterial blood pressure, peripheral vascular resistance) in response to food ingestion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 20, 2017
CompletedFirst Submitted
Initial submission to the registry
November 19, 2019
CompletedFirst Posted
Study publicly available on registry
November 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2020
CompletedMarch 30, 2020
November 1, 2019
2.4 years
November 19, 2019
March 27, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
The incremental area under curve for Insulin
The incremental area under curve for Insulin will be calculated using samples collected at 20 minute intervals between baseline and three hours
Over three hours from baseline
Secondary Outcomes (1)
The incremental area under curve for arterialized whole blood glucose
Over four hours from baseline
Other Outcomes (7)
The incremental area under curve for free fatty acids
Over three hours from baseline
The incremental area under curve for Triglycerides
Over three hours from baseline
The incremental area under curve for Ghrelin
Over four hours from baseline
- +4 more other outcomes
Study Arms (3)
Control
OTHER2 consecutive days of standardised daily levels of moderate physical activity (PAL=1.85 reflecting their habitual levels), and matched energy (food) intake
SIT+E
EXPERIMENTAL2 consecutive days of reduced physical activity induced by prolonged periods of sitting (PAL=1.4) whilst maintaining the level of food intake prescribed in the Control trial, thus creating a positive energy balance
SIT=E
EXPERIMENTAL2 consecutive days of reduced physical activity induced by prolonged periods of sitting (PAL=1.4) whilst reducing food intake to match the reduction in energy expenditure induced by inactivity, thus maintaining energy balance
Interventions
Eligibility Criteria
You may qualify if:
- Non-smoking
- Males and females
- Age (18-35 years old)
- Body mass index (BMI) of 18-27 kg/m2
- Waist circumference \<94cm for males and \<80cm for females
- Ability to give informed consent
You may not qualify if:
- Smoking
- Any metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism) or cardiovascular (e.g. heart or blood) abnormalities including hypertension or heart failure
- Clinically significant abnormalities on screening including ECG abnormalities
- Taking routine medication that may alter cardiovascular function and blood flow (e.g. blood pressure-lowering drugs or drugs that cause hypertension)
- Well trained individuals with PAL\>2.00; on an energy-restricted diet or seeking to lose weight
- High alcohol consumption (\<3-4 units/d for men; \<2-3 units/d for women)
- Females who are pregnant or lactating; self-reported allergy, intolerance or strong dislike of foods or drinks to be offered for the test breakfast, pasta meal or during the intervention period
- Beck Depression Inventory score \>10 and Eating Attitudes Test (EAT-26) score \>20 as self-reported markers of symptoms and concerns characteristic of depression and eating disorders, respectively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nottingham
Nottingham, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2019
First Posted
November 21, 2019
Study Start
October 20, 2017
Primary Completion
March 13, 2020
Study Completion
March 13, 2020
Last Updated
March 30, 2020
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
only anonymised individual personal data will be shared, upon specific request from other researchers, for example, in order to undertake a meta analysis